Elon Musk’s Neuralink is preparing to launch a speech trial in the US this October. The company wants to translate thoughts into text using a brain implant, a step that could transform how people with speech impairments communicate. Neuralink, already known for ambitious brain-computer interface projects, sees this trial as the start of a much larger journey.

From Medical Breakthroughs to Consumer Tech

Neuralink has secured FDA approval under an investigational device exemption, allowing the trial to move forward. Unlike earlier implants focused on motor control for paralyzed patients, this new device targets speech directly from the brain. Neuralink’s president, DJ Seo, revealed that the company hopes to reach healthy volunteers by 2030, marking a shift from medical necessity to consumer technology.

Thought-to-Text: Faster Than Speaking

Seo described a future where imagined words can be captured instantly. “If you’re imagining saying something, we could pick that up,” he explained. This direct connection could make communication faster than spoken language. Neuralink envisions users querying AI systems at the speed of thought and receiving instant responses through devices like wireless earbuds.

Competition in the Brain-Computer Race

Neuralink is one of several firms racing to build brain-computer interfaces. Current research shows progress in helping stroke and ALS patients, many of whom struggle to form words despite clear thinking. While other teams have published breakthroughs, no commercial device can yet read speech directly from the brain. Neuralink hopes to be the first to bring this capability to broader use.

Expanding Beyond Speech

The company’s ambitions extend far beyond communication. Neuralink is exploring treatments for blindness and Parkinson’s disease while scaling up to potentially implant 20,000 people annually by 2031. For now, the speech trial represents a major milestone in both medical technology and the path toward everyday consumer use.

Stay tuned to Maple Wire Now for the next news update.

The post Neuralink Speech Trial Aims to Turn Thoughts Into Text first appeared on Maple News Wire.

Elon Musk’s Neuralink brain chip has reached Canada, where two quadriplegic patients are now testing the technology in a groundbreaking clinical trial. The wireless device, designed to connect brain signals to external systems, allows users to control a computer by thought alone.

First Patients and Their Journey

The Canadian patients, both in their 30s—one from Ontario, the other from Alberta—underwent surgery at Toronto Western Hospital. Dr. Andres Lozano, a neurosurgeon with University Health Network, led the team that implanted the device. Within minutes, one patient was able to move a cursor simply by thinking. Both men were discharged the morning after their surgeries.

How the Technology Works

Electrodes are implanted into the brain’s motor region, capturing neuron signals. These signals are decoded by artificial intelligence, which then translates them into digital commands. As a result, users can type, play video games, or move a cursor without lifting a finger. The process is fast, precise, and offers new possibilities for independence.

Balancing Hope with Realism

While the results are exciting, experts urge caution. Barry Munro, chief development officer of the Canadian Spinal Research Organization, calls this “educated hope.” Having lived with quadriplegia for nearly four decades, he emphasizes the importance of measured expectations. Previous trials in the U.S. revealed complications, such as device slippage, highlighting that the technology is still in early stages.

Clinical Trial Goals in Canada

The Canadian trial will monitor patients for at least a year, with room for up to four more participants. Candidates may include individuals with spinal cord injuries or ALS. Researchers will evaluate safety, quality-of-life improvements, and potential risks such as seizures, strokes, or infections.

The Road Ahead for Neuralink

So far, the device allows basic functions like controlling a cursor or gaming. Yet, Dr. Lozano believes the technology could one day scale to driving wheelchairs, operating robots, or even controlling cars. The clinical trial marks an important step in determining if Neuralink can transition from experiment to everyday life-changing solution.

Stay updated instantly — follow us on Instagram | Facebook | X | LinkedIn

The post Neuralink Brain Chip Helps Canadians Control Computers by Thought first appeared on Maple News Wire.